Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

View source ↗

Summary

Observational real-world evidence study assessing paritaprevir/ritonavir-ombitasvir with or without dasabuvir and/or ribavirin in chronic hepatitis C patients i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ribavirin (ribavirin)
• paritaprevir/ritonavir-ombitasvir (paritaprevir/ritonavir-ombitasvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2019-07-26